Try our Advanced Search for more refined results
Life Sciences - October, 2013
282 articles
- J&J Gouged $2M For HIV Meds, Health Care Nonprofit Says
- Ranbaxy Sues Actavis To Block Generic Absorica Acne Drug
- Clinical Trial Deaths Lead Ariad To Halt Iclusig Sales
- J&J Unit Slapped With $4M Verdict Over Topamax Birth Defects
- Risky Business Of FDA Mobile Medical Apps
- AstraZeneca Discloses US Investigation Into Heart Drug Trial
- Biopharma Co. Misled Investors On Cancer Drug Progress: Suit
- FDA Launches Two-Prong Attack On Drug Shortages
- Sequenom Patent For Prenatal DNA Test Invalidated
- Deals Rumor Mill: Oaktree Capital, Barrick, General Atlantic
- Genentech Seeks Trim Of Eli Lilly's Patent Invalidation Suit
- 6th Circ. Won't Hear Appeal Of Darvocet Suit Remand
- Insurer Brings $3M Medpace Coverage Suit To Fed. Court
- Butler Snow Adds Baker Botts Product Liability Expert In NY
- FTC Says Marketer Exaggerated Weight Loss Claims
- Legal Demand Is Up — How Are Law Departments Managing?
- 4 Compliance-Focused Reforms That Would Improve FCA
- FDA Chides Sunovion Over Misstating Brovana Risks, Benefits
- Fed. Circ. Partially Revives AstraZeneca Asthma Drug IP Row
- K-V, Secured Lenders Reach $5M Deal To End Interest Row
- Okla. Supreme Court Gives Harsh Take On Abortion Drug Law
- AEIC Allowed To Seek $4M Fee In Clinical Trial Row
- Allergan Can't Beat Widower's Botox Poisoning Suit
- To Dodge Mensing, Plaintiffs May Target Foreign Drugmakers
- UK To Ban Hospitals' Use Of Many Metal Hip Implants
- Bill Risks Confusion To Curb FDA's Already-Lax App Oversight
- Synthes' Spinal Implant Patent Invalid, Fed. Circ. Affirms
- Takeaways From McPhee V. DePuy's Preemption Pronouncement
- Walgreens Sued Over Cartilage Rebuilding Supplement
- Honigman Miller Adds Patent Pro To IP Practice Group
- Sales Rep Claims Eli Lilly Reneged On Contract Incentives
- Star Scientific Says Shareholder Drug Suit Falls Short
- MedLab Seeks Ch. 11 Amid Medicare Reimbursement Cuts
- Jury Sides With Roche In Age Bias Trial
- FDA Proposes New Animal Food Safety Regs
- Canadian Court Won't Shrink Paxil Birth Defect Class
- Fed. Circ. Curbs Future Earnings Recovery In Vaccine Deaths
- Medicare Fraudster Can't Claim Double Jeopardy: 5th Circ.
- Valeant Will Pay Anacor $143M Over Anti-Fungal Dispute
- US Chamber, Others Push For Bill To Stop Counterfeit Imports
- Schulte Scores $21M Payday For Quigley Bankruptcy Work
- Catalyst's New Drug Was Old News, Investors Say
- Dow Pharmaceutical Asks Court To Block Generic Acne Gel
- Coming Soon: Paradigm Shift In Genetic Resources Regs
- Investors Rip Fee Request By Carella Byrne, Kessler Topaz
- Abbott Labs Wins FDA Approval For MitraClip Implant
- AstraZeneca Sues 4 Drugmakers To Stop Generic Vimovo
- FTC Pressed To Crack Down On Multilevel Marketers
- Hip Implant Recall Costs Could Top $1B, Stryker Says
- Novo Nordisk Recalls Insulin Pens All Over Europe
- DC Circ. Rejects Esai's Petition Over Seizure Med Delay
- Lumina Diet Supplement Class Action Stays In Fed. Court
- The Good, Bad And Ugly Of HIPAA-Compliant Texting
- US Chamber of Commerce Calls For False Claims Act Reform
- Ky. High Court Nixes Fen-Phen Malpractice Suit Against Firms
- FDA Pushes Tougher Controls On Hydrocodone Painkillers
- Nature's Products Hit With $3.3M Verdict Over Prolab Recall
- FDA Panel Chair Targeted Over Advice To Drug Cos.
- Senators Warn Of Possible Kickbacks Behind Back Surgeries
- AndroGel Judge Says It's Time To Revive Class Fight
- AstraZeneca Says Safe Harbor Dooms Crestor Patent Suit
- Digirad's Board Of Directors Election Valid, Judge Says
- The Inherent Risks In Purchasing Assets Of A Predecessor
- AARP Opposes 12-Year Exclusivity For Biologic Drugs In TPP
- USANA Flouted 'Live Person' Software License, Suit Says
- Stryker Settles FCPA Probe With $13M Payout
- GSK Can't Sink Avandia Prescription Coverage RICO Suits
- Effexor Pay-For-Delay Suit Awaits High Court's K-Dur Answer
- McKesson Inks $8.3B Deal To Scoop Up German Peer Celesio
- Troutman Sanders Nets Ex-McCarter Product Liability Atty
- FDA Urged To Get Specific In Facility Inspection Reports
- Generics Cos. Can't Pare Novartis Patent Infringement Suit
- Bipartisan Bill Would Curb FDA's Medical Apps Oversight
- Investor Can Lead SAC Class Action Despite Past Suits
- Olympus Surgical Says Rival Ignored Court Order In IP Case
- EFF Urges High Court To Strengthen Patent Claim Standards
- French Cos. Can't Shield Info From UK Antitrust Suits
- Former Bristol-Myers Exec Gets 1 Year For Insider Trading
- Fosun Pharma Unit Inks $533M Deal To Sell Medical IP Rights
- Cephalon Sues Eagle Over Plans For Liquid Treanda
- Defeating Economic Loss Claims In Pharma Class Actions
- Deals Rumor Mill: McKesson, Icahn, Safeway
- Omnicare Pays $120M To Settle Nursing Home Kickback Suit
- Judge Trims Doc's $2.2M Indemnity Suit Against Device Maker
- FDA's Stem Cell Oversight Faces Pivotal Test In DC Circ.
- Enzo's Contract Claims Over DNA Testing Tech Tossed
- EU Lawmakers Back Medical Device Reforms
- Genetics Testing Co. Seeks Out Ch. 11
- PE Firm Actis Sinks $48M Into India's Symbiotec Pharmalab
- NJ Court Tosses Columbia Labs Stock Drop Suit
- USPTO Explains AIA Review Deadline In Nixing St. Jude Case
- Takeda Sues Amneal Over Gout Drug Generic
- Baxter Says Generic Co. Infringed Hypertension Med Patent
- Bayer Hit With Trademark Suit Over Alka-Seltzer Brand
- Roche Diagnostics Denies Fired Manager's Age Bias Claims
- Gore Faces $1B In Patent Damages After Willfulness Finding
- Actelion Denied Judgment In Tracleer Antitrust Suit
- Arent Fox Nabs Ex-Dentons Patent Litigator
- New Walgreen Model Raises Privacy Concerns, Sen. Says
- Dodd-Frank Isn't For Foreign Whistleblowers, Judge Says
- FDA Cannot Regulate Stem Cell Treatments, DC Circ. Hears
- FDA Largely Rejects Prometheus Petition On Drug Risks
- EU-Canada Trade Pact Picks Up Industry, Gov't Backing
- High Court Won't Hear Novo Foreign Liability Case
- $2M Verdict Stands In Bard Vaginal Mesh Bellwether
- Anacor Scores $100M In Valeant Fungus Drug Feud
- How To Prepare Witnesses To Make (Not Break) Your Case
- A Lesson On Liability Risks For Device And Pharma Cos.
- Bulky Novartis Eyedrop Boxes Mislead Buyers, Calif. DAs Say
- Fed. Circ. Revives Bone Screw Patent Claim
- Fed. Circ. Won't Stop Transfer Of Eli Lilly Patent Suit
- Set The Right Tone For Risk Mitigation, Home And Abroad
- Keep An Eye On High Court's 2 Potential FCA Cases
- FDA Rebuffs Alimera Diabetes Eye Treatment Over Concerns
- McKesson Inks $37M Settlement In Drug Price-Rigging Suit
- Bard Pushes For Costs In Dropped Vaginal Mesh Bellwether
- GSK Dodges False Claims Kickback Suit Over HIV Drug
- Shutdown Threatens To Keep Product Safety Rules On Shelf
- Regulator Orders Becton, Rival To Tone Down Device Claims
- NYU Sues Pfizer Over Royalties For Cancer Drug Xalkori
- J&J Can't Stop Baby Sleep Aid False Ad Action
- Fed. Circ. Affirms Valeant Win In Antidepressant IP Battle
- FCA's Scope Widens As 8th Circ. Embraces Little-Used Theory
- PE-Backed Biotech Co. Egalet Prepares $69M IPO
- Pa. Justices Reject Wyeth's Appeal Of $11M Prempro Suit
- Boston Scientific To Pay $30M In Defibrillator FCA Suit
- Ariad Investor Says Drug Side Effects Led To Stock Drop
- Misbranded Drugs — A Danger To Physicians And Patients
- Deals Rumor Mill: BlackBerry, Men's Wearhouse, Nestle
- Bayer Escapes 60 Suits In Mass Tort Over Yaz, Yasmin
- Time Limit Dooms Nexium Antitrust Claims, AstraZeneca Says
- BioClinica Investors Lose Bid To Block $123M PE Takeover
- St. Jude Looks To Shoot Down Investors' Stock Fraud Suit
- Spotlight On State Urgent Care Regulation
- NAD Asks Supplement Maker To Ax Clinical Claims
- Zimmer, Marketer Push For Retrial In $28M Knee Injury Row
- Savient Gets Nod To Fund Ch. 11 Sale With Cash Collateral
- FDA Advises Against Antifungal Drug's Use In Studies
- Philips AirFloss Buyers Shafted In False Ad Deal, Group Says
- Braun Yanks Antibiotic Over Life-Threatening Particles
- 38 Drugmakers Tricked State Medicaid Agency, La. Says
- St. Jude Says Cancer Drug Research Infringes Patents
- AstraZeneca Unit Buys Biotech Co. Spirogen For $440M
- Supplements Contain Meth-Like Substance, Study Says
- Australian Regulators Target Caffeine Combo Stimulants
- FDA Lays Out Limits For Drug Impurities
- Herbalife Can't Dodge 'Pyramid Scheme' Class Action
- Supreme Court Won't Mull Hospira's Duty To Supply Drug
- Savient Pharmaceuticals Files For Ch. 11, Plans $55M Sale
- 8th Circ. Revives DOD Fraud Claims In Bayer FCA Suit
- Becton Seeks New Trial, Nix Of $114M Antitrust Verdict
- Robins Kaplan Lures FCA Pro From Justice Department
- Environ Lures Drinker Biddle Partner For GC Slot
- Calif. Governor Vetoes Biosimilars Substitution Bill
- Gov't Shutdown Impacts: Health Care Edition
- Clinton Group Pushes For CEO Ouster At Drugmaker XenoPort
- Dilworth Paxson Gave Negligent Advice, Cryogenics Co. Says
- Shareholders Hit Peregrine Pharma Over Exec Compensation
- Maine Law Muddles Liability In Drug Injury Suits
- Fed. Circ. Won't Review Ruling Nixing Cordis Stent Patents
- Coverage Row Over Teva Patent Deal Sent To Arbitration
- $9M Shaved From Novartis Jaw Injury Award By NY Judge
- Medtronic Surgery Advice Suit Not Preempted: Ind. Court
- The Best Question To Ask Your Potential Outside Counsel
- Deals Rumor Mill: KKR, Versace, Glencore
- Bard Berated For Fee Demand In Dropped Vaginal Mesh Suit
- Quest Says It's Not Infringing Myriad's Gene Patents
- FDA Eyes Ariad Leukemia Drug After Blood Clot Reports
- EU Panel Says Contraceptive Benefits Outweigh Clot Risks
- Making Refill Reminders: Not As Simple As You Think
- Merck KGaA Sues NJ Supplement Biz For Use Of Folate Mark
- Health Industry In Limbo As Shutdown Halts Rulemaking
- Shutdown Harms CDC's Outbreak Tracking, Dems Say
- Sen. Wants Probe Of Big Pharma Influence On Painkiller Regs
- Allergan Seeks Escape From Surgical Centers' Lap-Band Suit
- Challenges Under The French Sunshine Act
- Natrol Faces False Ad Suit Over Joint-Health Supplement
- Gibbons Snags Ex-Roche Chief Patent Counsel For IP Practice
- Van Bael & Bellis Draws Back Longtime Antitrust, IP Atty
- Jury Awards $29M To KFx In Suture Patent Row
- OIG Sounds Alarm On Medicare's $565M Sleep Study Bill
- Pharma Co. Misled Investors About Hepatitis Drug, Suit Says
- High Court Sets Stage For Momentous FCA Ruling
- FTC's Increasingly Aggressive Assertion Of Authority
- Device Maker Fights OIG's 'Inherently Suspect' Claim
- Maine Drug Importation Law Takes Effect Amid Controversy
- Ex-Eli Lilly Scientists Stole $55M In Secrets, Feds Say
- Pfizer Hit With Suit Claiming Lipitor Caused Diabetes
- Gov't Shutdown: A Setback For FDA's Momentum
- J&J Investors Defend Suit Over Ex-CEO's $175M Payout
- Calif. Gov. Signs Compounding Pharmacy Oversight Bill
- Gov't Shutdown Delays Merck's FDA Drug Hearing
- Butler Snow Lands Litigation Ace To Bolster Pharma Group
- Lessons From SIGA Technologies V. PharmAthene
- DePuy Says Ex-Sales Reps Breached Noncompetes
- FDA Links Deadly Hepatitis Cluster To Popular Supplement
- GNC Seeks Toss Of Muscle Supplement False Ad Row
- Quest Buys ConVerge Diagnostic Services From Water Street
- Bard Wants Atty Fees For Dropped Mesh Bellwether
- FDA Chides Device Maker Nidek Over Quality Controls
- Deals Rumor Mill: McKesson, Vodafone, Carlyle
- Stryker OK'd To File New Knee Coverage Claims Against TIG
- Jones Day Adds Ex-SDNY Civil Frauds Unit Chief
- Arent Fox Lures IP Guru From Dentons To SF Office
- EU Lawmakers Loosen E-Cig Regs In Anti-Tobacco Plan
- Let's Really Consider The Idea Of A 2-Year Law Degree
- Sun Pharma Can't Quell Patent Feud Over Epilepsy Drug
- Former Celgene Exec Settles SEC's Insider Trading Claims
- High Court Won't Block Puerto Rico's Control Of Drug Prices
- High Court Won't Mull Punitives In Drug Labeling Suits
- Stryker Unit Settles Trade Secrets Claims Against Zimmer
- Justices Won't Hear Design Defect Suit Over Generic Reglan
- J&J Escapes Damages In Suit Linking Body Powder To Cancer
- Pasteur Gene Targeting Patents Are Valid, Fed. Circ. Told
- Watchdog Shuts Down Supragenix, Wellnx Supplement Claims
- Judge Unveils Records In FOIA Suit Targeting Pfizer, Purdue
- High Court Wants SG's Views In Medtronic Pain Pump Row
- High Court Rejects Appeal To Reclassify Marijuana
- Pa. Superior Court Won't Rehear Reglan Preemption Appeal
- High Court Wants Government Input In Whistleblower Suits
- High Court Won't Review Feraheme Investor Class Action
- CSL To Pay $64M To Escape Blood Plasma Antitrust Suit
- Calif. Class Consumer Fraud Cases Continue To Survive
- Novartis' Sandoz Infringed On Pfizer Eye Drug Patents: Judge
- Liberty Medical Asks For SJ In $69M Whistleblower Claim
- High Court Asked To Review Nixed $600M Stent IP Verdict
- FDA Quality Grades Could Leave Drugmakers Smarting
- The Best Cyberdefense Is A Good Offense
- Adderall Antitrust Suit Should Stay Buried, 2nd Circ. Hears
- Judge Delays Wind-Down In MDL Over Merck's Fosamax
- Polsinelli's FDA Practice Leader Jumps To Fox Rothschild
- House Bill Would End Shutdown For FDA
- Deals Rumor Mill: BNP Paribas, Ikaria, Best Buy
- Dems Back Funding Bill Tied To Repeal Of ACA Device Tax
- Mass. House OKs Bill To Reform Compounding Regs
- VasoNova, CR Bard Settle Catheter Trade Secrets Case
- JPML Ships Loestrin Pay-For-Delay Suits To Rhode Island
- Holland & Knight Nabs Pharmaceutical Pro For IP Practice
- Neptune Tech. Settles ITC Action Over Krill Oil Patent
- J&J Settles Hip Implant Case Set For Trial In Calif.
- Celgene Accused Of Infringing Cancer Treatment Patent
- Considerations Before Counseling During Deposition
- Masimo Escapes FCA Row Over Allegedly Shoddy Devices
- Hospira Woes Continue As Glass Contamination Spurs Recall
- Dutch Court Sides With Teva In Spat Over MS Drug Patent
- Declaratory Judgment Act: Must Suppliers Bet The Farm?
- Arthrex Ordered To Stop Selling Infringing Suture Anchors
- Vitamin C Attys Get $10M For Work On Antitrust Settlements
- Omeros To Get $12.5M In Whistleblower Coverage Deal
- Ackman Pares Down $1B Herbalife Bet, Books Losses
- Biosimilars Guidance, Drugmaker Grades Coming, FDA Says
- Merck Opposes Delay In Wind-Down Of Fosamax MDL
- BioScrip Inc. Hit With Shareholder Suit Over Exjade Probe
- Fla.'s Recent Fight In The Zometa Evidentiary Battle
- Fed. Circ. Lifts Injunction On Hanmi's Generic Nexium
- Questcor Can't Kick Securities Fraud Case
- 3rd Circ. Ruling Imperils Consumer Class Actions, Group Says
- FDA Lays Out Rules For Early Study Of Higher-Risk Devices
- McDonald Hopkins Picks Up Ex-K&L Gates Health Care Pro
- Avista, Nordic Ink $439M Deal To Acquire Swiss Drugmaker
- Mako Bulks Up Surgical Biz Before $1.7B Stryker Takeover
- New Bill Would Perpetuate FDA-State Compounding Confusion
- Merck's $688M Vytorin Settlement Wins Judge's Nod
- Medical Co. Settles With US Over Iran Embargo Violations
- Wright Pushes FTC For More Pay-For-Delay Study
- FDA Withdrawing Approval For Some Toxic Animal Feed Drugs
- Pharma Trade Group Seeks To Stop HHS Orphan Drug Rule
- Shutdown Status Of Top 7 Gov't Antitrust Cases
- Rainmaker Q&A: Chamblee Ryan's Bill Chamblee
- Stryker Hit With Patent Suit Over Spinal Treatment Devices
- FDA Warns Of Potential Safety Issues In Nephron Asthma Drug
- Deals Rumor Mill: America Movil, Icahn, J&J
- Novartis Takes Aim At Cross-Appeal In Zometa Suit
- Don't Conflate Shutdown And Debt Ceiling Challenges
- FDA Details When It Won't Accept Generic Drug Applications
- Amgen, Actavis Close On Billion-Dollar Pharma Deals
- Pharmaceutical Patent Pro Joins Baker Botts In Houston
- Catheter Kickback FCA Suit Brings No New Proof, Bard Says
- Epstein Becker Green Adds Health Care Pro To Newark Office
- US Government Shuts Down As Funding Fight Goes Nowhere
- BigLaw Braces For Revenue Hit In Federal Shutdown
- User Fees Won't Save FDA Approvals From Shutdown's Snare